default author photo

Francesco Vaia

Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI

SCHOLARLY PAPERS

3

DOWNLOADS

197

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against SARS-CoV-2 in People Living with HIV (PLWH) Receiving Antiretroviral Therapy (ART) According with Current CD4 T-Lymphocyte Count

Number of pages: 39 Posted: 24 Sep 2021
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Division of Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, University College London - Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Health Direction, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Health Direction, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Risk Management, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI and Independent
Downloads 95 (720,278)
Citation 3

Abstract:

Loading...

HIV, AIDS, antiSARS-CoV-2 vaccine, Immunogenicity

2.

Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)

Number of pages: 38 Posted: 05 Dec 2022
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Fondazione Policlinico Universitario A. Gemelli IRCCS - Section of Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, ASST Santi Paolo e Carlo, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Department of Systems Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata - Faculty of Medicine and Surgery, University of Rome Tor Vergata - Department of Systems Medicine, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Milan - Clinic of Infectious Diseases and Tropical Medicine, Lazzaro Spallanzani National Institute for Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department and Independent
Downloads 65 (924,743)

Abstract:

Loading...

Interleukin-6 receptor inhibitors, Sarilumab, SARS-CoV-2 infection, Severe COVID-19 pneumonia, randomized clinical trial

3.

SARS-CoV-2 Nasopharyngeal Viral Load in Individuals Infected with BA.2, Compared to Alpha, Gamma, Delta and BA.1 Variants: A Single-Center Comparative Analysis

Number of pages: 23 Posted: 29 Jul 2022
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University College London - Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department
Downloads 37 (1,222,651)

Abstract:

Loading...

SARS-CoV-2, Variants Of Concern (VOCs), nasopharyngeal viral load, Cycle Threshold (CT) values, increased transmissibility, Omicron BA.2